Bibliographic Details
| Title: |
Cytomegalovirus Blood DNAemia in Patients with Severe SARS-CoV-2 Pneumonia. |
| Authors: |
Mesland, Jean-Baptiste, Collienne, Christine, Montiel, Virginie, Werion, Alexis, Hantson, Philippe, Wittebole, Xavier, Laterre, Pierre-François, Gerard, Ludovic |
| Source: |
Infectious Disease Reports; Feb2025, Vol. 17 Issue 1, p8, 8p |
| Subject Terms: |
LENGTH of stay in hospitals, ARTIFICIAL respiration, REGRESSION analysis, CRITICALLY ill, SARS-CoV-2 |
| Abstract: |
Introduction: Cytomegalovirus (CMV) DNAemia has been described in critically ill patients, including patients with severe acute respiratory syndrome-coronavirus2 (SARS-CoV-2) infection. Our objective is to evaluate the prevalence and clinical impact of CMV DNAemia among patients undergoing invasive mechanical ventilation (IMV) for severe SARS-CoV-2 infection and to explore the association between CMV DNAemia levels and clinical outcomes. Methods: In this retrospective monocentric study, we included patients admitted in a tertiary ICU for severe COVID-19 and who required IMV. We aimed to compare clinical and demographic variables between patients with and without CMV DNAemia. Univariate and Cox regression analyses were performed to identify factors associated with CMV DNAemia. Results: During the study period, CMV blood DNAemia occurred in 30/135 patients (22%). Patients with CMV blood DNAemia had longer ICU and hospital length of stay, as well as longer duration of IMV, and were more likely to have received dexamethasone. However, there was no significant difference in ICU mortality between patients with and without CMV DNAemia (64.8% vs. 56.7%, p = 0.42). The Cox regression analysis showed that dexamethasone was the only factor independently associated with CMV blood DNAemia (HR 4.23 [1.006–17.792], p = 0.049). Conclusions: In patients with severe SARS-CoV-2 pneumonia requiring IMV, CMV DNAemia is common and associated with prolonged ventilation and increased LOS but not with increased mortality. [ABSTRACT FROM AUTHOR] |
|
Copyright of Infectious Disease Reports is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
|
Full text is not displayed to guests. |
Login for full access.
|
